Search Results - "ELWOOD, Lori"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans by RUBIN, J. T, ELWOOD, L. J, ROSENBERG, S. A, LOTZE, M. T

    Published in Cancer research (Chicago, Ill.) (15-12-1989)
    “…We have evaluated immunohistochemical characteristics of tumors and the infiltrating cells in patients treated with various immunotherapy regimens. Forty-eight…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies by Smith, 2nd, J W, Urba, W J, Curti, B D, Elwood, L J, Steis, R G, Janik, J E, Sharfman, W H, Miller, L L, Fenton, R G, Conlon, K C

    Published in Journal of clinical oncology (01-07-1992)
    “…A phase I trial was undertaken because interleukin-1 alpha (IL-1 alpha) possesses antiproliferative, immunostimulatory, antiinfection, myeloprotective, and…”
    Get more information
    Journal Article
  4. 4

    A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer by Gilbert, L, Elwood, L J, Merino, M, Masood, S, Barnes, R, Steinberg, S M, Lazarous, D F, Pierce, L, d'Angelo, T, Moscow, J A

    Published in Journal of clinical oncology (01-01-1993)
    “…Previous studies have indicated that RNA levels for pi-class glutathione S-transferase (GST pi), a phase II, drug-metabolizing enzyme, were inversely related…”
    Get more information
    Journal Article
  5. 5

    Angiocentric immunoproliferative lesions: a molecular analysis of eight cases by Medeiros, L J, Peiper, S C, Elwood, L, Yano, T, Raffeld, M, Jaffe, E S

    Published in Human pathology (1991)
    “…Angiocentric immunoproliferative lesions (AILs) are believed to represent a unique type of extranodal malignant lymphoma on the basis of clinicopathologic and…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma by Walther, M M, Gnarra, J R, Elwood, L, Xu, H J, Florence, C, Anglard, P, Hu, S X, King, C, Trahan, E, Hurley, K

    Published in The Journal of urology (01-06-1995)
    “…Tumor suppressor genes have been found to have loss of function in a number of malignancies. This loss of function is believed to contribute to malignant…”
    Get more information
    Journal Article
  8. 8

    A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer by BATES, S. E, MEADOWS, B, GOLDSPIEL, B. R, DENICOFF, A, TUNG BA LE, TUCKER, E, STEINBERG, S. M, ELWOOD, L. J

    “…Increasing evidence suggests that P-glycoprotein (Pgp) expression can mediate drug resistance in refractory breast cancer. We studied 33 patients with…”
    Get full text
    Journal Article
  9. 9

    Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial by Steis, R G, VanderMolen, L A, Longo, D L, Clark, J W, Smith, 2nd, J W, Kopp, W C, Ruscetti, F W, Creekmore, S P, Elwood, L J, Hursey, J

    “…We evaluated the toxic, hematopoietic, and immunomodulatory effects of recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF). The…”
    Get more information
    Journal Article
  10. 10

    Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype by van Krieken, JH, Elwood, L, Andrade, RE, Jaffe, ES, Cossman, J, Medeiros, LJ

    Published in The American journal of pathology (01-07-1991)
    “…The configuration of the T-cell receptor (TCR) delta chain gene was assessed using restriction fragment analysis and the Southern blot technique in 39 T-cell…”
    Get full text
    Journal Article